公司创建于2017年,由多位医学博士创立,获得*风投基金注资,将致力于干细胞新药的研发和生产,秉承管理创新、技术创新和产品创新理念,与中国新药同行一起,携手并肩,砥砺奋进,共同为国内*先进的干细胞药物努力。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows